Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Accumulated Depreciation (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Accumulated Depreciation data on record, last reported at $4.4 million in Q4 2025.

  • For Q4 2025, Accumulated Depreciation rose 10.23% year-over-year to $4.4 million; the TTM value through Dec 2025 reached $4.4 million, up 10.23%, while the annual FY2025 figure was $4.4 million, 10.23% up from the prior year.
  • Accumulated Depreciation reached $4.4 million in Q4 2025 per PLSE's latest filing, up from $4.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation topped out at $4.4 million in Q4 2025 and bottomed at $2.4 million in Q4 2021.
  • Average Accumulated Depreciation over 5 years is $3.4 million, with a median of $3.4 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation: grew 25.05% in 2021, then rose 10.23% in 2025.
  • A 5-year view of Accumulated Depreciation shows it stood at $2.4 million in 2021, then increased by 23.25% to $3.0 million in 2022, then rose by 17.71% to $3.5 million in 2023, then grew by 14.15% to $4.0 million in 2024, then grew by 10.23% to $4.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation were $4.4 million in Q4 2025, $4.2 million in Q2 2025, and $4.0 million in Q4 2024.